Atlas Trials

Lenvatinib Following Liver Transplantation in Patients of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus

Clinical trial NCT04319484 · UNKNOWN

Trial details

NCT number
NCT04319484
Sponsor
RenJi Hospital
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Hepatocellular CarcinomaPortal Vein Tumor ThrombusLiver Transplantation
Start date
2020-05-02
Primary completion
2025-01-01
Enrollment
108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.